The strong beat and raised guidance confirm DaVita's operational execution. Monitor for potential upside to FY guidance as the year progresses; the continued buyback supports EPS growth. Competitor FMS may also benefit from positive sector sentiment.
Price Chart
Executive Summary
DaVita reported Q1 2026 revenue of $3.416B (+6% YoY) and GAAP diluted EPS of $2.87, beating the Street consensus of $2.41 by 19%. The company raised its FY2026 adjusted EPS guidance to $14.10-$15.20 from $13.60-$15.00, signaling sustained operating momentum and margin expansion.
Key Financial Metrics
Key Facts
- Revenue of $3.416B (+6% YoY) beat consensus.
- GAAP diluted EPS of $2.86 (actually $2.87) beat Street consensus of $2.41 by 19%.
- FY2026 adjusted EPS guidance raised to $14.10-$15.20 from $13.60-$15.00.
- Aggressive buyback: 3.0M shares for $403M in Q1, plus 2.0M for $302M after quarter-end.
- Integrated kidney care risk-based patients declined to 62,600 from 66,000 sequentially.
Financial Impact
EPS beat by $0.46 vs consensus, revenue beat by ~$56M vs notional consensus, guidance raised at the low end by $0.50.
Risk Factors
- Declining integrated kidney care patient count may signal challenges in value-based care.
- Rising operating costs (patient care costs per treatment up 3% YoY) could pressure margins.
- Potential regulatory changes (Medicare reimbursement, OBBBA) remain unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000927066-26-000060 |
| Document: dva-20260505.htm | 0000927066-26-000060 |
| Document: 0000927066-26-000060-index-headers.html | 0000927066-26-000060 |
| Document: 0000927066-26-000060-index.html | 0000927066-26-000060 |
| Document: 0000927066-26-000060.txt | 0000927066-26-000060 |
| 8-K Data (Synthetic) | 0000927066-26-000060 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 8w ago | 8-K | $187.61 $178.83 | ▼ −4.68% | ▼ −4.08% | $178.69 (−4.75%) |
Jun 15, 2026 15w ago | Court Ruling | $209.75 $232.41 | ▲ +10.80% | ▲ +11.20% | $178.69 (−14.81%) |
Jun 8, 2026 16w ago | 8-K | $198.19 $234.31 | ▲ +18.22% | ▲ +16.78% | $178.69 (−9.84%) |
May 18, 2026 19w ago | Insider Cluster | $194.38 $208.98 | ▲ +7.51% | ▲ +5.25% | $178.69 (−8.07%) |
May 13, 2026 20w ago | Insider Cluster | $192.30 $208.66 | ▼ −8.51% | ▼ −9.37% | $178.69 (+7.08%) |
May 5, 2026 21w ago | 8-K | $191.76 $195.03 | ▲ +1.71% | ▼ −1.07% | $178.69 (−6.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access